HEADER DNA BINDING PROTEIN 19-FEB-08 3CAG TITLE CRYSTAL STRUCTURE OF THE OLIGOMERIZATION DOMAIN HEXAMER OF THE TITLE 2 ARGININE REPRESSOR PROTEIN FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX TITLE 3 WITH 9 ARGININES. COMPND MOL_ID: 1; COMPND 2 MOLECULE: ARGININE REPRESSOR; COMPND 3 CHAIN: A, B, C, D, E, F; COMPND 4 FRAGMENT: C-TERMINAL DOMAIN: RESIDUES 92-170; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS; SOURCE 3 ORGANISM_TAXID: 83332; SOURCE 4 STRAIN: H37RV; SOURCE 5 ATCC: 25618; SOURCE 6 GENE: ARGR, AHRC, RV1657, MT1695, MTCY06H11.22; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYSS; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_VECTOR: PDEST-15; SOURCE 12 EXPRESSION_SYSTEM_PLASMID: PGST-1657 KEYWDS L-ARGININE REPRESSOR, DNA BINDING PROTEIN, OLIGOMERIZATION DOMAIN, KEYWDS 2 CORE, ALPHA/BETA TOPOLOGY, TBSGC, STRUCTURAL GENOMICS, TB STRUCTURAL KEYWDS 3 GENOMICS CONSORTIUM, AMINO-ACID BIOSYNTHESIS, ARGININE BIOSYNTHESIS, KEYWDS 4 DNA-BINDING, TRANSCRIPTION, TRANSCRIPTION REGULATION, PSI-2, PROTEIN KEYWDS 5 STRUCTURE INITIATIVE EXPDTA X-RAY DIFFRACTION AUTHOR L.T.CHERNEY,M.M.CHERNEY,C.R.GAREN,G.J.LU,M.N.G.JAMES,TB STRUCTURAL AUTHOR 2 GENOMICS CONSORTIUM (TBSGC) REVDAT 6 30-AUG-23 3CAG 1 REMARK REVDAT 5 25-OCT-17 3CAG 1 REMARK REVDAT 4 13-JUL-11 3CAG 1 VERSN REVDAT 3 24-FEB-09 3CAG 1 VERSN REVDAT 2 02-SEP-08 3CAG 1 JRNL REVDAT 1 18-MAR-08 3CAG 0 JRNL AUTH L.T.CHERNEY,M.M.CHERNEY,C.R.GAREN,G.J.LU,M.N.JAMES JRNL TITL STRUCTURE OF THE C-TERMINAL DOMAIN OF THE ARGININE REPRESSOR JRNL TITL 2 PROTEIN FROM MYCOBACTERIUM TUBERCULOSIS. JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 64 950 2008 JRNL REFN ISSN 0907-4449 JRNL PMID 18703843 JRNL DOI 10.1107/S0907444908021513 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.26 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.4 REMARK 3 NUMBER OF REFLECTIONS : 34288 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.171 REMARK 3 R VALUE (WORKING SET) : 0.168 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1793 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.95 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1997 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 76.67 REMARK 3 BIN R VALUE (WORKING SET) : 0.1900 REMARK 3 BIN FREE R VALUE SET COUNT : 109 REMARK 3 BIN FREE R VALUE : 0.2430 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3393 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 108 REMARK 3 SOLVENT ATOMS : 357 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.61 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.70000 REMARK 3 B22 (A**2) : 1.78000 REMARK 3 B33 (A**2) : -1.07000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.153 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.150 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.089 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.942 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.961 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.931 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3640 ; 0.015 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4939 ; 1.483 ; 1.998 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 462 ; 5.776 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 153 ;33.849 ;21.765 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 595 ;15.528 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 51 ;15.397 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 606 ; 0.099 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2745 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1798 ; 0.217 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2442 ; 0.301 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 349 ; 0.153 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 45 ; 0.146 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 21 ; 0.178 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2455 ; 0.960 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3806 ; 1.432 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1276 ; 2.616 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1133 ; 4.057 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3CAG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-FEB-08. REMARK 100 THE DEPOSITION ID IS D_1000046541. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-MAY-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.10552 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36125 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.6 REMARK 200 DATA REDUNDANCY : 6.900 REMARK 200 R MERGE (I) : 0.13200 REMARK 200 R SYM (I) : 0.13200 REMARK 200 FOR THE DATA SET : 15.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 84.6 REMARK 200 DATA REDUNDANCY IN SHELL : 6.80 REMARK 200 R MERGE FOR SHELL (I) : 0.42200 REMARK 200 R SYM FOR SHELL (I) : 0.42200 REMARK 200 FOR SHELL : 4.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2ZFZ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.45 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12% PEG 10000, 0.1M HEPES PH 7.0, 0.2M REMARK 280 L-ARGININE, 10% GLYCEROL, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.87250 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 54.01100 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.82400 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 54.01100 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.87250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.82400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: AUTHORS STATE THAT THE ASYMMETRIC UNIT CONTAINS ONE HEXAMER REMARK 300 THAT IS A DIMER OF TRIMERS. EITHER HEXAMER OR TRIMER MIGHT BE THE REMARK 300 BIOLOGICAL UNIT. ACCORDING TO AUTHORS, THE THREE ADDITIONAL LIGANDS REMARK 300 (ARG 400) MAY BE RANDOMLY DISTRIBUTED BETWEEN BIOMOLECULES 2 AND 3. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9470 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16620 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -18.7 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3260 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9950 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3030 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9840 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -11.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 92 REMARK 465 GLY A 93 REMARK 465 GLY D 92 REMARK 465 GLY F 92 REMARK 465 GLY F 93 REMARK 465 THR F 94 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER C 111 116.36 -161.04 REMARK 500 SER D 111 118.21 -160.99 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ARG A 300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ARG B 300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ARG C 300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ARG D 300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ARG E 300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ARG F 300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ARG A 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ARG B 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ARG C 400 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: RV1657 RELATED DB: TARGETDB REMARK 900 RELATED ID: 2ZFZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN HEXAMER OF ARGININE REMARK 900 REPRESSOR FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH 6 REMARK 900 ARGININE MOLECULES REMARK 900 RELATED ID: 3BUE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN HEXAMER OF ARGININE REMARK 900 REPRESSOR FROM MYCOBACTERIUM TUBERCULOSIS DBREF 3CAG A 92 170 UNP P0A4Y8 ARGR_MYCTU 92 170 DBREF 3CAG B 92 170 UNP P0A4Y8 ARGR_MYCTU 92 170 DBREF 3CAG C 92 170 UNP P0A4Y8 ARGR_MYCTU 92 170 DBREF 3CAG D 92 170 UNP P0A4Y8 ARGR_MYCTU 92 170 DBREF 3CAG E 92 170 UNP P0A4Y8 ARGR_MYCTU 92 170 DBREF 3CAG F 92 170 UNP P0A4Y8 ARGR_MYCTU 92 170 SEQRES 1 A 79 GLY GLY THR ASP ARG MET ALA ARG LEU LEU GLY GLU LEU SEQRES 2 A 79 LEU VAL SER THR ASP ASP SER GLY ASN LEU ALA VAL LEU SEQRES 3 A 79 ARG THR PRO PRO GLY ALA ALA HIS TYR LEU ALA SER ALA SEQRES 4 A 79 ILE ASP ARG ALA ALA LEU PRO GLN VAL VAL GLY THR ILE SEQRES 5 A 79 ALA GLY ASP ASP THR ILE LEU VAL VAL ALA ARG GLU PRO SEQRES 6 A 79 THR THR GLY ALA GLN LEU ALA GLY MET PHE GLU ASN LEU SEQRES 7 A 79 ARG SEQRES 1 B 79 GLY GLY THR ASP ARG MET ALA ARG LEU LEU GLY GLU LEU SEQRES 2 B 79 LEU VAL SER THR ASP ASP SER GLY ASN LEU ALA VAL LEU SEQRES 3 B 79 ARG THR PRO PRO GLY ALA ALA HIS TYR LEU ALA SER ALA SEQRES 4 B 79 ILE ASP ARG ALA ALA LEU PRO GLN VAL VAL GLY THR ILE SEQRES 5 B 79 ALA GLY ASP ASP THR ILE LEU VAL VAL ALA ARG GLU PRO SEQRES 6 B 79 THR THR GLY ALA GLN LEU ALA GLY MET PHE GLU ASN LEU SEQRES 7 B 79 ARG SEQRES 1 C 79 GLY GLY THR ASP ARG MET ALA ARG LEU LEU GLY GLU LEU SEQRES 2 C 79 LEU VAL SER THR ASP ASP SER GLY ASN LEU ALA VAL LEU SEQRES 3 C 79 ARG THR PRO PRO GLY ALA ALA HIS TYR LEU ALA SER ALA SEQRES 4 C 79 ILE ASP ARG ALA ALA LEU PRO GLN VAL VAL GLY THR ILE SEQRES 5 C 79 ALA GLY ASP ASP THR ILE LEU VAL VAL ALA ARG GLU PRO SEQRES 6 C 79 THR THR GLY ALA GLN LEU ALA GLY MET PHE GLU ASN LEU SEQRES 7 C 79 ARG SEQRES 1 D 79 GLY GLY THR ASP ARG MET ALA ARG LEU LEU GLY GLU LEU SEQRES 2 D 79 LEU VAL SER THR ASP ASP SER GLY ASN LEU ALA VAL LEU SEQRES 3 D 79 ARG THR PRO PRO GLY ALA ALA HIS TYR LEU ALA SER ALA SEQRES 4 D 79 ILE ASP ARG ALA ALA LEU PRO GLN VAL VAL GLY THR ILE SEQRES 5 D 79 ALA GLY ASP ASP THR ILE LEU VAL VAL ALA ARG GLU PRO SEQRES 6 D 79 THR THR GLY ALA GLN LEU ALA GLY MET PHE GLU ASN LEU SEQRES 7 D 79 ARG SEQRES 1 E 79 GLY GLY THR ASP ARG MET ALA ARG LEU LEU GLY GLU LEU SEQRES 2 E 79 LEU VAL SER THR ASP ASP SER GLY ASN LEU ALA VAL LEU SEQRES 3 E 79 ARG THR PRO PRO GLY ALA ALA HIS TYR LEU ALA SER ALA SEQRES 4 E 79 ILE ASP ARG ALA ALA LEU PRO GLN VAL VAL GLY THR ILE SEQRES 5 E 79 ALA GLY ASP ASP THR ILE LEU VAL VAL ALA ARG GLU PRO SEQRES 6 E 79 THR THR GLY ALA GLN LEU ALA GLY MET PHE GLU ASN LEU SEQRES 7 E 79 ARG SEQRES 1 F 79 GLY GLY THR ASP ARG MET ALA ARG LEU LEU GLY GLU LEU SEQRES 2 F 79 LEU VAL SER THR ASP ASP SER GLY ASN LEU ALA VAL LEU SEQRES 3 F 79 ARG THR PRO PRO GLY ALA ALA HIS TYR LEU ALA SER ALA SEQRES 4 F 79 ILE ASP ARG ALA ALA LEU PRO GLN VAL VAL GLY THR ILE SEQRES 5 F 79 ALA GLY ASP ASP THR ILE LEU VAL VAL ALA ARG GLU PRO SEQRES 6 F 79 THR THR GLY ALA GLN LEU ALA GLY MET PHE GLU ASN LEU SEQRES 7 F 79 ARG HET ARG A 300 12 HET ARG A 400 24 HET ARG B 300 12 HET ARG B 400 24 HET ARG C 300 12 HET ARG C 400 24 HET ARG D 300 12 HET ARG E 300 12 HET ARG F 300 12 HETNAM ARG ARGININE FORMUL 7 ARG 9(C6 H15 N4 O2 1+) FORMUL 16 HOH *357(H2 O) HELIX 1 1 THR A 94 LEU A 105 1 12 HELIX 2 2 ALA A 123 ALA A 135 1 13 HELIX 3 3 THR A 158 ARG A 170 1 13 HELIX 4 4 GLY B 92 LEU B 105 1 14 HELIX 5 5 ALA B 123 ALA B 135 1 13 HELIX 6 6 THR B 158 ASN B 168 1 11 HELIX 7 7 GLY C 92 LEU C 105 1 14 HELIX 8 8 ALA C 123 ALA C 135 1 13 HELIX 9 9 THR C 158 ARG C 170 1 13 HELIX 10 10 GLY D 93 LEU D 105 1 13 HELIX 11 11 ALA D 123 ALA D 135 1 13 HELIX 12 12 THR D 158 ARG D 170 1 13 HELIX 13 13 GLY E 92 LEU E 105 1 14 HELIX 14 14 ALA E 123 ALA E 135 1 13 HELIX 15 15 THR E 158 ARG E 170 1 13 HELIX 16 16 ARG F 96 LEU F 105 1 10 HELIX 17 17 ALA F 123 ALA F 135 1 13 HELIX 18 18 THR F 158 ARG F 170 1 13 SHEET 1 A 4 SER A 107 SER A 111 0 SHEET 2 A 4 LEU A 114 ARG A 118 -1 O VAL A 116 N ASP A 109 SHEET 3 A 4 THR A 148 ALA A 153 -1 O ILE A 149 N LEU A 117 SHEET 4 A 4 VAL A 139 ALA A 144 -1 N GLY A 141 O VAL A 152 SHEET 1 B 4 SER B 107 SER B 111 0 SHEET 2 B 4 LEU B 114 ARG B 118 -1 O VAL B 116 N ASP B 109 SHEET 3 B 4 THR B 148 ALA B 153 -1 O VAL B 151 N ALA B 115 SHEET 4 B 4 VAL B 139 ALA B 144 -1 N VAL B 140 O VAL B 152 SHEET 1 C 4 SER C 107 SER C 111 0 SHEET 2 C 4 LEU C 114 ARG C 118 -1 O VAL C 116 N ASP C 109 SHEET 3 C 4 THR C 148 ALA C 153 -1 O VAL C 151 N ALA C 115 SHEET 4 C 4 VAL C 139 ALA C 144 -1 N GLY C 141 O VAL C 152 SHEET 1 D 4 SER D 107 SER D 111 0 SHEET 2 D 4 LEU D 114 ARG D 118 -1 O ARG D 118 N SER D 107 SHEET 3 D 4 THR D 148 ALA D 153 -1 O VAL D 151 N ALA D 115 SHEET 4 D 4 VAL D 139 ALA D 144 -1 N VAL D 140 O VAL D 152 SHEET 1 E 4 SER E 107 SER E 111 0 SHEET 2 E 4 LEU E 114 ARG E 118 -1 O VAL E 116 N ASP E 109 SHEET 3 E 4 THR E 148 ALA E 153 -1 O VAL E 151 N ALA E 115 SHEET 4 E 4 VAL E 139 ALA E 144 -1 N VAL E 140 O VAL E 152 SHEET 1 F 4 SER F 107 SER F 111 0 SHEET 2 F 4 LEU F 114 ARG F 118 -1 O VAL F 116 N ASP F 109 SHEET 3 F 4 THR F 148 ALA F 153 -1 O VAL F 151 N ALA F 115 SHEET 4 F 4 VAL F 139 ALA F 144 -1 N VAL F 140 O VAL F 152 CISPEP 1 GLU A 155 PRO A 156 0 4.36 CISPEP 2 GLU B 155 PRO B 156 0 7.00 CISPEP 3 GLU C 155 PRO C 156 0 7.54 CISPEP 4 GLU D 155 PRO D 156 0 5.95 CISPEP 5 GLU E 155 PRO E 156 0 8.05 CISPEP 6 GLU F 155 PRO F 156 0 1.66 SITE 1 AC1 14 HIS A 125 ALA A 128 SER A 129 ASP A 132 SITE 2 AC1 14 THR A 142 ILE A 143 ALA A 144 GLY C 145 SITE 3 AC1 14 ASP C 146 ASP C 147 THR C 148 PRO F 121 SITE 4 AC1 14 GLY F 122 ASP F 146 SITE 1 AC2 12 GLY A 145 ASP A 146 ASP A 147 THR A 148 SITE 2 AC2 12 HIS B 125 ALA B 128 ASP B 132 THR B 142 SITE 3 AC2 12 ILE B 143 ALA B 144 PRO E 121 ASP E 146 SITE 1 AC3 13 GLY B 145 ASP B 146 ASP B 147 THR B 148 SITE 2 AC3 13 HIS C 125 ALA C 128 ASP C 132 THR C 142 SITE 3 AC3 13 ILE C 143 ALA C 144 PRO D 121 GLY D 122 SITE 4 AC3 13 ASP D 146 SITE 1 AC4 11 ASP C 146 HIS D 125 ALA D 128 ASP D 132 SITE 2 AC4 11 THR D 142 ILE D 143 ALA D 144 GLY F 145 SITE 3 AC4 11 ASP F 146 ASP F 147 THR F 148 SITE 1 AC5 13 PRO B 121 ASP B 146 GLY D 145 ASP D 146 SITE 2 AC5 13 ASP D 147 THR D 148 HIS E 125 ALA E 128 SITE 3 AC5 13 SER E 129 ASP E 132 THR E 142 ILE E 143 SITE 4 AC5 13 ALA E 144 SITE 1 AC6 12 PRO A 121 ASP A 146 GLY E 145 ASP E 146 SITE 2 AC6 12 ASP E 147 THR E 148 HIS F 125 ALA F 128 SITE 3 AC6 12 ASP F 132 THR F 142 ILE F 143 ALA F 144 SITE 1 AC7 14 GLY A 122 ALA A 124 HIS A 125 GLY A 145 SITE 2 AC7 14 ASP A 146 GLY B 122 HIS B 125 GLY E 122 SITE 3 AC7 14 ALA E 124 HIS E 125 GLY E 145 ASP E 146 SITE 4 AC7 14 GLY F 122 HIS F 125 SITE 1 AC8 14 GLY B 122 ALA B 124 HIS B 125 GLY B 145 SITE 2 AC8 14 ASP B 146 GLY C 122 HIS C 125 GLY D 122 SITE 3 AC8 14 ALA D 124 HIS D 125 GLY D 145 ASP D 146 SITE 4 AC8 14 GLY E 122 HIS E 125 SITE 1 AC9 14 GLY A 122 HIS A 125 GLY C 122 ALA C 123 SITE 2 AC9 14 ALA C 124 HIS C 125 GLY C 145 ASP C 146 SITE 3 AC9 14 HIS D 125 GLY F 122 ALA F 124 HIS F 125 SITE 4 AC9 14 GLY F 145 ASP F 146 CRYST1 57.745 75.648 108.022 90.00 90.00 90.00 P 21 21 21 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017318 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013219 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009257 0.00000